Cheol Keun Park

7PUBLICATIONS
19CO-AUTHORS
Molecular targetsCancer geneticsPredictive and prognostic markersLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 21, 2023
Androgen-Independent Prostate Cancer Is Sensitive to CDC42-PAK7 Kinase Inhibition.

Hyunho Han, Cheol Keun Park, Young-Deuk Choi

|Nov 11, 2022
Characteristics of BRCA2 Mutated Prostate Cancer at Presentation.

Hyunho Han, Cheol Keun Park, Nam Hoon Cho

|Dec 29, 2019
HoxB13 expression in ductal type adenocarcinoma of prostate: clinicopathologic characteristics and its utility as potential diagnostic marker.

Cheol Keun Park, Su-Jin Shin, Yoon Ah Cho

|Jul 20, 2018
Diagnostic algorithm for determining primary tumor sites using peritoneal fluid.

Cheol Keun Park, Douglas P Malinowski, Nam Hoon Cho

|Aug 01, 2017
External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma.

Jung Yun Lee, Young Shin Chung, Kiyong Na

|Jun 01, 2017
Clinicopathological characteristics of KIT and protein kinase C-δ expression in adenoid cystic carcinoma: comparison with chromophobe renal cell carcinoma and gastrointestinal stromal tumour.

Cheol Keun Park, Won Kyu Kim, Hoguen Kim

Pageof 2

Frequent Collaborators

3 joint publications

Nam Hoon Cho

2 joint publications

Kang Su Cho

2 joint publications

Young-Deuk Choi

2 joint publications

Jongsoo Lee